Data Brief | No. 57 | October 2019

Virginia Residents Worried about High Drug Costs - Support a Range of Government Solutions

According to a survey of 1,172 adults, Virginians are extremely concerned about prescription drug costs and express a strong desire to enact solutions. 

Half (50%) of all survey respondents reported being either “worried” or “very worried” about affording the cost of prescription drugs. The uninsured, those that purchase private coverage individually and those on Medicaid were the most concerned about affording drugs (see Figure 1).


Hub-Altarum Data Brief No. 57 - Virginia High Drug Prices Figure 1.png


Concerns about affording drugs may be tied to concerns about the security of health coverage. As detailed in a companion data brief,1 many respondents worried about losing their health coverage or being unable to afford their insurance, with those on Medicaid and those that buy private insurance coverage on their own (not through an employer) having the highest rates of insurance worry. 

In addition to high levels of worry, many Virginia residents experienced hardship due to drug costs. One in four (27%) of survey respondents reported not filling a prescription and/or cutting pills in half in the prior 12 months due to concerns about cost (see Figure 2).


Hub-Altarum Data Brief No. 57 - Virginia High Drug Prices Fig2.png


In light of concerns about high healthcare costs—including prescription drug costs—it is not surprising that Virginia residents were extremely dissatisfied with the health system:

  • Only 28% agreed or strongly agreed with the statement “We have a great health care system in the U.S.”
  • While 74% agreed or strongly agreed “the system needs to change.” 

When given more than 20 options, the option cited most frequently as being a “major reason” for high healthcare costs were drug companies charging too much money:

  • 73%—Drug companies charging too much money 
  • 63%—Hospitals charging too much money 
  • 62%—Insurance companies charging too much money 
  • 55%—Some well-known or large hospitals or doctor groups using their influence to get higher payments from insurance companies 

When it comes to tackling high drug costs specifically, respondents endorsed a number of strategies:

  • 88%—Authorize the attorney general to take legal action to prevent price gouging or unfair prescription drug price hikes
  • 88%—Require drug companies to provide advanced notice of price increases and information to justify those increases
  • 85%—Set standard prices for drugs to make them affordable
  • 85%—Prohibit drug companies from charging more in the U.S. than abroad 

What is remarkable about the findings is high support for change regardless of the respondent’s political affiliation (see Table 1).


Hub-Altarum Data Brief No. 57 - Virginia High Drug Prices Table 1.png


While government action was strongly viewed as more effective to address high drug costs, respondents also saw a role for themselves in solving problems. They reported actions they have already taken, like researching the cost of drug beforehand (61%), as well as future actions—80% believe that switching to a generic if given the option is one of the top things they can do personally to address affordability.

Note

1. See: Healthcare Value Hub, Virginia Residents Struggle to Afford High Healthcare Costs; Support a Range of Government Solutions Across Party Lines, Data Brief No. 42 (July 2019). www.healthcarevaluehub.org/Virginia-2019-Healthcare-Survey/

Methodology

Altarum’s Consumer Healthcare Experience State Survey (CHESS) is designed to elicit respondents’ unbiased views on a wide range of health system issues, including confidence using the health system, financial burden, and views on fixes that might be needed. 

The survey used a web panel from SSI Research Now containing a demographically balanced sample of approximately 1,200 respondents who live in Virginia. The survey was conducted from March 12 through April 2, 2019 only in English and restricted to adults ages 18 and older. Respondents who finished the survey in less than half the median time were excluded from the final sample, leaving 1,172 cases for analysis with sample balancing occurring in age, gender and income to be demographically representative of Virginia. After those exclusions, the demographic composition of respondents is as follows.

Hub-Altarum Data Brief No. 57 - Virginia High Drug Prices Demo Table.png